DRIO and LS1P Related Headlines
Go Back- Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Therapies Through Precision Behavioral Support: 79% of Members Already Using Dario's Weight Management
- Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Health's Most Evidence-Based Platforms
- Dario Launches DarioIQ™ AI Integration in Dario Health App with Direct-to-Consumer First Version for Hypertension Members
- Dario's Data-Driven Digital Health Platform Delivers Significant and Sustainable Improvements in Blood Pressure: Findings Published in JMIR Cardio
- DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year
- DarioHealth Presents New Data Demonstrating Significant Reduction in Medical Costs Among Employer Populations Using Its Digital Health Platform
- Dario Signs 6 New Employer Clients Representing Tens of Thousands of Lives Deepening its Leadership in Value-Based Care
- DarioHealth partners with OneStep for fall risk assessment technology
- DarioHealth and OneStep Announce Strategic Collaboration to Integrate Smartphone-Only, Clinical-Grade Fall Risk Assessment Technology into Dario's Digital Health Multi-Condition Platform
- DarioHealth Announces Strategic Review Following Multiple Unsolicited Inbound Expressions of Interest
- DarioHealth raises $17.5 million in private placement at $6.45 per share
- DarioHealth Announces $17.5 Million Private Placement of Common Stock Priced At-The-Market Under Nasdaq Rules
- DarioHealth Issues Shareholder Update: Multi-Condition Leadership in Momentum Driven Digital Health Market
- Dario Secures Five New Employer Contracts Across Cardiometabolic Suite Including its Largest Employer to Date, Contributing to Annual Recurring Revenues Beginning Q3 2025
- DarioHealth implements 20-to-1 reverse stock split effective August 28
- DarioHealth Announces 20-to-1 Reverse Stock Split
- DarioHealth Reports Second Quarter 2025 Financial and Operating Results
- DarioHealth to Report Second Quarter 2025 Results on Tuesday, August 12, 2025
- DarioHealth (DRIO) and GreenKey partner to target sleep apnea market
- Dario and GreenKey Health Announce Strategic Commercial Agreement to Transform Chronic Condition Management and Sleep Health for Payers Nationwide
- Dario Unveils Groundbreaking GLP-1 and AI-Personalization Digital Health Findings
DRIO and LS1P Related Press Releases
Go Back- Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Therapies Through Precision Behavioral Support: 79% of Members Already Using Dario's Weight Management
- Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Health's Most Evidence-Based Platforms
- Dario Launches DarioIQ™ AI Integration in Dario Health App with Direct-to-Consumer First Version for Hypertension Members
- Dario's Data-Driven Digital Health Platform Delivers Significant and Sustainable Improvements in Blood Pressure: Findings Published in JMIR Cardio
- DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year
- DarioHealth Presents New Data Demonstrating Significant Reduction in Medical Costs Among Employer Populations Using Its Digital Health Platform
- Dario Signs 6 New Employer Clients Representing Tens of Thousands of Lives Deepening its Leadership in Value-Based Care
- DarioHealth and OneStep Announce Strategic Collaboration to Integrate Smartphone-Only, Clinical-Grade Fall Risk Assessment Technology into Dario's Digital Health Multi-Condition Platform
- DarioHealth Announces Strategic Review Following Multiple Unsolicited Inbound Expressions of Interest
- DarioHealth Announces $17.5 Million Private Placement of Common Stock Priced At-The-Market Under Nasdaq Rules
- DarioHealth Issues Shareholder Update: Multi-Condition Leadership in Momentum Driven Digital Health Market
- Dario Secures Five New Employer Contracts Across Cardiometabolic Suite Including its Largest Employer to Date, Contributing to Annual Recurring Revenues Beginning Q3 2025
- DarioHealth Announces 20-to-1 Reverse Stock Split
- DarioHealth Reports Second Quarter 2025 Financial and Operating Results
- DarioHealth to Report Second Quarter 2025 Results on Tuesday, August 12, 2025
- Dario and GreenKey Health Announce Strategic Commercial Agreement to Transform Chronic Condition Management and Sleep Health for Payers Nationwide
- Dario Unveils Groundbreaking GLP-1 and AI-Personalization Digital Health Findings
